Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1423053 MIAMI, FL
Back to BBIO Full portfolio

Position in BBIO

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$280,046,885
+$44,350,102 QoQ
Shares Held
3,760,028
+18.5% QoQ
Ownership
1.92%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#12
of 473 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Derivatives in BBIO

reported options exposure · as of Jun 30, 2026
CallValue
$21,278,936
CallShares
285,700
PutValue
$20,943,776
PutShares
281,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,739,871 across 435 Biotechnology names. BBIO ranks #2 (4.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
This page 		3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in BBIO

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,943,776 281,200
2026-06-30 $280,046,885 3,760,028
2026-06-30 $21,278,936 285,700
2026-03-31 $235,696,783 3,173,940
2026-03-31 $4,062,022 54,700
2026-03-31 $12,000,416 161,600
2025-12-31 $53,403,940 698,182
2025-12-31 $34,229,275 447,500
2025-12-31 $8,520,986 111,400
2025-09-30 $6,627,544 127,600
2025-09-30 $14,402,962 277,300
2025-06-30 $7,785,354 180,300
2025-06-30 $14,349,792 332,325
2025-06-30 $7,370,826 170,700
2025-03-31 $7,902,702 228,600
2025-03-31 $101,325,809 2,931,033
2025-03-31 $8,881,033 256,900
2024-12-31 $34,447,105 1,255,361
2024-12-31 $10,515,008 383,200
2024-12-31 $8,232,000 300,000
2024-09-30 $5,840,524 229,400
2024-09-30 $5,893,990 231,500
2024-09-30 $74,906,221 2,942,114
2024-06-30 $7,928,290 313,000
2024-06-30 $5,220,513 206,100
2024-06-30 $54,622,852 2,156,449
2024-03-31 $3,045,620 98,500
2024-03-31 $10,908,576 352,800
2024-03-31 $27,310,863 883,275
2023-12-31 $26,811,936 664,155
2023-12-31 $13,015,288 322,400
2023-12-31 $3,290,155 81,500
2023-09-30 $14,995,564 568,660
2023-09-30 $3,399,093 128,900
2023-09-30 $8,596,620 326,000
2023-06-30 $9,430,760 548,300
2023-06-30 $7,114,092 413,610
2023-06-30 $5,087,760 295,800
2023-03-31 $3,946,040 238,000
2023-03-31 $4,622,504 278,800
2023-03-31 $4,754,015 286,732
2022-12-31 $21,924,172 2,877,188
2022-12-31 $463,296 60,800
2022-12-31 $110,490 14,500
2022-09-30 $18,001,459 1,811,012
2022-09-30 $298,200 30,000
2022-09-30 $437,360 44,000
2022-06-30 $469,436 51,700
2022-06-30 $449,460 49,500
2022-06-30 $7,643,488 841,794